Sales for the quarter ended at MNOK 102.6 (MNOK 103.1), on par with the sales
record set in Q1 last year. Currency neutral, sales increased by 1.5%.  Second
best quarter ever for operating result (EBIT) at MNOK 29.0 (MNOK 24.8), an
increase of 17.3% over last year. EBIT margin was 28.3%. Medistim partners with
LivaNova as distributor for India.	The General Assembly decided to pay a
dividend of NOK 3.00 per share.

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange